ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2463
0,01%
Bitcoin
67.630,00
0,22%
Brent Oil
81,295
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Frequency Therapeutics Inc (FREQ)

  7. Frequency Therapeutics Inc (FREQ) Notícias

FREQ

Frequency Therapeutics (FREQ)

Frequency Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:FREQ
DataHoraFonteTítuloCódigoCompanhia
01/05/202418:18Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:FREQFrequency Therapeutics Inc
29/04/202408:47Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:FREQFrequency Therapeutics Inc
29/04/202408:42Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:FREQFrequency Therapeutics Inc
26/04/202417:01Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:FREQFrequency Therapeutics Inc
24/04/202420:33Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:FREQFrequency Therapeutics Inc
24/04/202418:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FREQFrequency Therapeutics Inc
22/04/202418:14Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:FREQFrequency Therapeutics Inc
22/04/202418:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FREQFrequency Therapeutics Inc
19/04/202417:06Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:FREQFrequency Therapeutics Inc
28/03/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FREQFrequency Therapeutics Inc
26/03/202418:09Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:FREQFrequency Therapeutics Inc
26/03/202418:03Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FREQFrequency Therapeutics Inc
26/03/202417:02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:FREQFrequency Therapeutics Inc
06/11/202319:22Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FREQFrequency Therapeutics Inc
02/11/202317:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FREQFrequency Therapeutics Inc
25/10/202317:01Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:FREQFrequency Therapeutics Inc
28/09/202307:06Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:FREQFrequency Therapeutics Inc
21/08/202316:39Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FREQFrequency Therapeutics Inc
10/08/202317:01Business WireFrequency Therapeutics Provides Business Updates and Second Quarter 2023 Financial ResultsNASDAQ:FREQFrequency Therapeutics Inc
27/07/202318:28Edgar (US Regulatory)Form S-4 - Registration of securities, business combinationsNASDAQ:FREQFrequency Therapeutics Inc
14/07/202307:30Business WireKorro Bio and Frequency Therapeutics Announce Merger AgreementNASDAQ:FREQFrequency Therapeutics Inc
13/07/202316:43Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:FREQFrequency Therapeutics Inc
12/07/202322:25Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:FREQFrequency Therapeutics Inc
20/06/202317:34Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:FREQFrequency Therapeutics Inc
06/06/202317:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FREQFrequency Therapeutics Inc
12/05/202317:07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FREQFrequency Therapeutics Inc
12/05/202317:01Business WireFrequency Therapeutics Provides Business Updates and First Quarter 2023 Financial ResultsNASDAQ:FREQFrequency Therapeutics Inc
01/05/202317:17Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:FREQFrequency Therapeutics Inc
10/03/202309:42Edgar (US Regulatory)Annual Report (10-k)NASDAQ:FREQFrequency Therapeutics Inc
10/03/202309:30Business WireFrequency Therapeutics Provides Business Updates and Fourth Quarter and Full Year 2022 Financial ResultsNASDAQ:FREQFrequency Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:FREQ

Seu Histórico Recente

NYSE
JHX
James Hardie Industries
EU
I3ABN
LS 3ABN INAV
ASX
SPSDA
EU
PRM4S
Sg Issuer null
BIT
P1P3V4
BNP Paribas Issuance
USOTC
PSBYP
Link Parks (CE)
LSE
56QY
Stn.ch.bk.31
BIT
XLVS
Invesco Health Care S&P ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados